Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

D William Clark


  • Director at Arsanis Inc. (ASNS), 2017-11-15
  • President And Ceo at Genocea Biosciences Inc. (GNCA), 2017-03-01
  • Sr. Vp, Chief Business Officer at Vanda Pharmaceuticals Inc. (VNDA), 2010-02-23
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
GNCA $3.49 2,800 Officer, Director 52,205 2016-11-07 Filing
GNCA $6.45 3,800 Officer, Director 43,607 2015-12-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
VNDA $10.65 9,522 Officer 168,279 2010-02-19 Filing
VNDA $11.05 217,749 Officer 152,801 2009-12-14 Filing